This study examined the expression of ANXA2 and HE4 in endometrial carcinoma cells using western blot and immunocytochemistry, and confirmed their interaction in endometrial carcinoma cells through co-immunoprecipitation and double-labelling immunofluorescence. Here, ANXA2 is linked to endometrial carcinoma.